Related Experiment Video

Updated: Jul 7, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Are platelets a 'forgotten' source of sepsis-induced myocardial depressing factor(s)?

Alexandre Mebazaa

    Critical Care (London, England)
    |February 8, 2008
    PubMed

    Insights

    Platelet-derived exosomes may contribute to sepsis-induced heart dysfunction by releasing myocardial depressant substances. Further clinical research is needed to confirm this mechanism of cardiac failure in sepsis.

    Area of Science:

    • Cardiology
    • Sepsis Research
    • Cellular Biology

    Background:

    • Sepsis-induced cardiac failure is a complex condition with multifactorial causes.
    • Historically, 'myocardial depressant' substances were implicated in sepsis-related heart dysfunction.
    • Platelets are increasingly recognized for their role in inflammatory and cardiovascular diseases.

    Discussion:

    • Exosomes, particularly those released by platelets, are emerging as critical mediators in intercellular communication.
    • These platelet-derived exosomes carry various bioactive molecules that can influence cardiac function.
    • Their presence in plasma during sepsis suggests a potential role in mediating myocardial depression.

    Key Insights:

    • Platelet-derived exosomes are proposed as a key factor in sepsis-induced myocardial depression.
    • These exosomes may contain and transport substances that directly impair heart muscle function.
    • This offers a novel cellular mechanism contributing to sepsis pathophysiology.

    Outlook:

    • Clinical studies are essential to validate the role of platelet exosomes in human sepsis.
    • Investigating exosome content may reveal therapeutic targets for sepsis-induced cardiac dysfunction.
    • Further research can elucidate the precise molecular pathways involved.

    More Related Videos

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    Related Concept Videos

    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Inflammation01:38

    Inflammation

    Overview
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...